
FLOW provides exposure to companies that generate a high level of free cash flow, an indicator of profitability. The fund maintains a portfolio of large- and mid-sized US companies selected based on their trailing 12-month free cash flow yield. Initially, the fund considers the top 1,000 US companies by market-cap. Companies exhibiting negative free cash flow yield over the past 12 months and firms operating in the financial sector are excluded. Among the remaining eligible securities, the fund selects the top 100 based on their free cash flow yield over the preceding 12-month period and…
Is FLOW's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Rising Treasury yields and market weakness raise concerns for U.S. stocks. Explore ETF areas that could offer resilience.

Ray Dalio warns that rising bond yields could pressure stocks. Explore five cash-flow-focused ETFs to identify financially resilient companies.

Flow Traders 3Q 2026 Pre-Close Call Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) publishes the 3Q 2026 pre-close call script to be used with analysts post the market close on 24 September 2026. Welcome to the Flow Traders 3Q 2026 pre-close call, which is being conducted post the European market close on 24 September.

SNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its proprietary FLOW~IQ◊ technology with an adjustable-angle tip, the FLOW FLEXTEND Wand is designed to give surgeons enhanced joint access1 * and precise tissue targeting3 for hard-to-reach hip, knee and shoulder anatomies.